MERIT MEDICAL SYSTEMS INC 10-Q

ITEM 5. OTHER INFORMATION During the fiscal quarter ended June 30, 2024, none of our directors or officers informed us of the adoption or termination of a “Rule 10 b5-1 trading arrangement” or “non-Rule 10 b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408 . ​ 43 Table of Contents ITEM 6. EXHIBITS Exhibit No. Description 2.1 ​ Asset Purchase Agreement, dated July 1, 2024, by and between Merit Medical Systems, Inc. and Endogastric Solutions, Inc. 3.1 ​ Second Amended and Restated Articles of Incorporation.* 3.2 ​ Fourth Amended and Restated Bylaws.* 10.1 ​ Indemnification Agreement dated May 15, 2024 between Merit Medical Systems, Inc. and Silvia M. Perez.* 10.2 ​ Form of Restricted Stock Unit Award Agreement, dated May 16, 2024, by and between Merit Medical Systems, Inc. and each of the following individuals: Lonny J. Carpenter, Stephen C. Evans, David K. Floyd, Thomas J. Gunderson, Laura S. Kaiser, Michael R. McDonnell, F. Ann Millner, Lynne N. Ward and Silvia M. Perez.† 31.1 ​ Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 . 31.2 ​ Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 . 32.1 ​ Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 . 32.2 ​ Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 . 101 ​ The following financial information from the quarterly report on Form 10-Q for the quarter ended June 30, 2024, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) related Condensed Notes to the Unaudited Consolidated Financial Statements, tagged in detail. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document). ​ * These exhibits are incorporated herein by reference. † Indicates management contract or compensatory plan or arrangement. ​ ​ ​ 44 Table of Contents ​ SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ​ ​ ​ ​ ​ MERIT MEDICAL SYSTEMS, INC. ​ ​ ​ Date: August 1, 2024 By: /s/ FRED P. LAMPROPOULOS ​ ​ Fred P. Lampropoulos, President and ​ ​ Chief Executive Officer ​ ​ ​ ​ Date: August 1, 2024 By: /s/ RAUL PARRA ​ ​ Raul Parra ​ ​ Chief Financial Officer and Treasurer ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 45